$5.84
arrow_drop_up3.54%Key Stats | |
---|---|
Open | $5.75 |
Prev. Close | $5.78 |
EPS | -0.90 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 5.56 | 5.85 |
52 Week Range | 1.96 | 6.91 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.90 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
Design Therapeutics, Inc. (DSGN) Upgraded to Buy: Here's What You Should Know
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024